# Codex Review: medical_monitoring_risk_disposition_high_risk_authorization_20260804

Date: 2026-08-04 (Asia/Shanghai)
Delegated-agent output: none; direct Codex implementation.

## Verdict

**PASS pending review-gate closure.** Both disposition writes now
use the exact action and high-risk evidence contract.

## Boundary Check

- Work stayed inside workbench source, tests and this task's durable records.
- No service, browser, provider, API login, runtime DB, migration or real
  project was touched.

## Codex Verification

- `RuxRiskDispositionActionRequest` carries optional reauthentication and
  SHA-256 signature evidence fields for the compatibility API boundary.
- Both risk-disposition handlers canonicalize, require server identity, bind
  `CHANGE_RISK_DISPOSITION` with `high_risk=True`, and replace payload actor
  with `principal.server_actor` before the inbox service.
- Focused authorization/disposition/inbox suite: **37 passed, 17 existing
  warnings, 15.84s**; targeted `py_compile` passed.
- Full `tests/test_monitoring*.py`: **1943 passed, 25 existing warnings,
  500.72s**, exit code 0. Hermes review-gate is the remaining formal closure
  check.

## Delegated-Agent Output Review

- No delegated output was used. The route/action decision is traceable to the
  existing action matrix; no generic write action was reused.
- Frontend reauthentication UX and generic inbox actions are intentionally
  outside this slice.

## Residual Risk

Host verified-session middleware is absent, so production dispositions remain
fail-closed with 503. Until a real reauthentication/signature adapter and UI
are connected, valid server sessions still need explicit evidence fields.
B6/C14, source-token/CAS, approved-input, controlled runtime and real-project
UAT remain closed.
